Suppr超能文献

诱导表达消除了肠球菌万古霉素耐药性的适应性代价。

Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.

机构信息

Unité des Agents Antibactériens, Institut Pasteur, 75724 Paris Cedex 15, France.

出版信息

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16964-9. doi: 10.1073/pnas.1006855107. Epub 2010 Sep 10.

Abstract

Inducible vancomycin resistance in enterococci is due to a sophisticated mechanism that combines synthesis of cell wall peptidoglycan precursors with low affinity for glycopeptides and elimination of the normal target precursors. Although this dual mechanism, which involves seven genes organized in two operons, is predicted to have a high fitness cost, resistant enterococci have disseminated worldwide. We have evaluated the biological cost of VanB-type resistance due to acquisition of conjugative transposon Tn1549 in Enterococcus faecium and Enterococcus faecalis. Because fitness was dependent on the integration site of Tn1549, an isogenic set of E. faecalis was constructed to determine the cost of inducible or constitutive expression of resistance or of carriage of Tn1549. A luciferase gene was inserted in the integrase gene of the transposon to allow differential quantification of the strains in cocultures and in the digestive tract of gnotobiotic mice. Both in vitro and in vivo, carriage of inactivated or inducible Tn1549 had no cost for the host in the absence of induction by vancomycin. In contrast, induced or constitutively resistant strains not only had reduced fitness but were severely impaired in colonization ability and dissemination among mice. These data indicate that tight regulation of resistance expression drastically reduces the biological cost associated with vancomycin resistance in Enterococcus spp. and accounts for the widespread dissemination of these strains. Our findings are in agreement with the observation that regulation of expression is common in horizontally acquired resistance and represents an efficient evolutionary pathway for resistance determinants to become selectively neutral.

摘要

肠球菌的诱导型万古霉素耐药性是由于一种复杂的机制,该机制结合了细胞壁肽聚糖前体的合成与对糖肽的低亲和力,以及正常靶前体的消除。尽管这种涉及 7 个基因的两个操纵子组织的双重机制预计具有高适应性成本,但耐药肠球菌已在全球范围内传播。我们评估了由于获得接合转座子 Tn1549 而导致的 VanB 型耐药性的生物学成本,这种转座子存在于屎肠球菌和粪肠球菌中。由于 Tn1549 的整合位点决定了适应性,因此构建了一组屎肠球菌的同基因系,以确定诱导或组成型表达耐药性或携带 Tn1549 的成本。转座子的整合酶基因中插入了一个荧光素酶基因,以允许在共培养物中和无菌小鼠的消化道中对菌株进行差异定量。无论是在体外还是在体内,在没有万古霉素诱导的情况下,携带失活或诱导型 Tn1549 对宿主没有成本。相比之下,诱导型或组成型耐药菌株不仅适应性降低,而且在定植能力和在小鼠之间的传播能力方面严重受损。这些数据表明,对耐药性表达的严格调控大大降低了肠球菌属中与万古霉素耐药性相关的生物学成本,并解释了这些菌株的广泛传播。我们的研究结果与以下观察结果一致,即表达的调控在水平获得的耐药性中很常见,并且代表了抗性决定因素成为选择性中性的有效进化途径。

相似文献

1
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16964-9. doi: 10.1073/pnas.1006855107. Epub 2010 Sep 10.
2
Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.
Antimicrob Agents Chemother. 2006 Mar;50(3):1054-62. doi: 10.1128/AAC.50.3.1054-1062.2006.
3
Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp.
Microbiology (Reading). 2000 Jun;146 ( Pt 6):1481-1489. doi: 10.1099/00221287-146-6-1481.
4
Characteristics of Vancomycin-Resistant Enterococcus Strains in the West Balkans: A First Report.
Microb Drug Resist. 2017 Jan;23(1):122-126. doi: 10.1089/mdr.2015.0355. Epub 2016 Jun 28.
5
Vancomycin resistant Enterococci: A brief review.
J Pak Med Assoc. 2018 May;68(5):768-772.
6
New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.
Antimicrob Agents Chemother. 2009 May;53(5):1952-63. doi: 10.1128/AAC.01348-08. Epub 2009 Mar 2.
7
Multisite Detection of Tn-Mediated Vancomycin Resistance in Multidrug-Resistant Enterococcus faecalis ST6 in Texas and Florida.
Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0128422. doi: 10.1128/aac.01284-22. Epub 2022 Dec 21.
9
VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
Antimicrob Agents Chemother. 2004 Oct;48(10):3892-904. doi: 10.1128/AAC.48.10.3892-3904.2004.

引用本文的文献

2
Reversion to sensitivity explains limited transmission of resistance in a hospital pathogen.
bioRxiv. 2024 Jun 3:2024.06.03.597162. doi: 10.1101/2024.06.03.597162.
3
Recent advances in nanoantibiotics against multidrug-resistant bacteria.
Nanoscale Adv. 2023 Oct 5;5(23):6278-6317. doi: 10.1039/d3na00530e. eCollection 2023 Nov 21.
5
Vancomycin Resistance in and .
Microorganisms. 2022 Dec 21;11(1):24. doi: 10.3390/microorganisms11010024.
7
Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.
PLoS Biol. 2022 Sep 28;20(9):e3001808. doi: 10.1371/journal.pbio.3001808. eCollection 2022 Sep.
8
Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.
Biomed Res Int. 2022 Sep 5;2022:5419874. doi: 10.1155/2022/5419874. eCollection 2022.
9
Amplification of the Chromosomal Gene in Escherichia coli Expanding the Spectrum of Resistance under Antimicrobial Pressure.
Microbiol Spectr. 2022 Jun 29;10(3):e0031922. doi: 10.1128/spectrum.00319-22. Epub 2022 Apr 25.
10
Lenzimycins A and B, Metabolites With Antibacterial Properties From sp. Associated With the Dung Beetle .
Front Microbiol. 2020 Oct 30;11:599911. doi: 10.3389/fmicb.2020.599911. eCollection 2020.

本文引用的文献

1
Antibiotic resistance and its cost: is it possible to reverse resistance?
Nat Rev Microbiol. 2010 Apr;8(4):260-71. doi: 10.1038/nrmicro2319. Epub 2010 Mar 8.
2
In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.
Appl Environ Microbiol. 2010 Jan;76(1):264-74. doi: 10.1128/AEM.01686-09. Epub 2009 Oct 30.
3
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009 Jun;53(6):2354-9. doi: 10.1128/AAC.01702-08. Epub 2009 Mar 30.
4
Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria.
FEMS Microbiol Rev. 2008 Mar;32(2):386-408. doi: 10.1111/j.1574-6976.2007.00097.x. Epub 2008 Feb 11.
5
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
Clin Infect Dis. 2008 Mar 1;46(5):668-74. doi: 10.1086/527392.
6
The cost of expression of Escherichia coli lac operon proteins is in the process, not in the products.
Genetics. 2008 Mar;178(3):1653-60. doi: 10.1534/genetics.107.085399. Epub 2008 Feb 3.
7
Modes and modulations of antibiotic resistance gene expression.
Clin Microbiol Rev. 2007 Jan;20(1):79-114. doi: 10.1128/CMR.00015-06.
8
Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications.
Anal Biochem. 2007 Feb 15;361(2):253-62. doi: 10.1016/j.ab.2006.10.043. Epub 2006 Nov 21.
9
Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.
Antimicrob Agents Chemother. 2006 Mar;50(3):1054-62. doi: 10.1128/AAC.50.3.1054-1062.2006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验